Second Quarter 2023 Earnings

Presentation

August 8, 2023

Forward-Looking Statements and Non-GAAP Financial Results

This presentation ("Presentation") is for informational purposes only. This Presentation shall not constitute an offer to sell, or the solicitation of an offer to buy, any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation or sale would be unlawful.

No representations or warranties, express or implied, are given in, or in respect of, this Presentation. To the fullest extent permitted by law in no circumstances will Danimer Scientific, Inc. (the "Company") or any of its subsidiaries, stockholders, affiliates, representatives, directors, officers, employees, advisers, or agents be responsible or liable for a direct, indirect, or consequential loss or loss of profit arising from the use of this Presentation, its contents, its omissions, reliance on the information contained within it, or on opinions communicated in relation thereto or otherwise arising in connection therewith. Industry and market data used in this Presentation have been obtained from third-party industry publications and sources as well as from research reports prepared for other purposes. The Company has not

independently verified the data obtained from these sources and cannot assure you of the data's accuracy or completeness. This data is subject to change. In addition, this Presentation does not purport to be all-inclusive or to contain all of the information that may be required to make a full analysis of investigations as an investor may deem necessary.

FORWARD-LOOKING STATEMENTS

Please note that in this Presentation, we may use words such as "appears," "anticipates," "believes," "plans," "expects," "intends," "future," and similar expressions which constitute forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, statements regarding our expectations for full year 2023 capital expenditures and Adjusted EBITDA. Forward-looking statements are made based on management's expectations and beliefs concerning future events impacting the Company and therefore involve a number of risks and uncertainties. The Company cautions that forward-looking statements are not guarantees and that actual results could differ materially from those expressed or implied in the forward- looking statements. Potential risks and uncertainties that could cause the actual results of operations or financial condition of the Company to differ materially from those expressed or implied by forward-looking statements in this Presentation include, but are not limited to, the overall level of consumer demand on its products; general economic conditions and other factors affecting consumer confidence, preferences, and behavior; disruption and volatility in the global currency, capital, and credit markets; the financial strength of the Company's customers; the Company's ability to implement its business strategy, including, but not limited to, its ability to expand its production facilities and plants to meet customer demand for its products and the timing thereof; risks relating to the uncertainty of the projected financial information with respect to the Company; the ability of the Company to execute and integrate acquisitions; changes in governmental regulation, legislation or public opinion relating to its products; the Company's exposure to product liability or product warranty claims and other

loss contingencies; disruptions and other impacts to the Company's business, as a result of the COVID-19 global pandemic and government actions and restrictive measures implemented in response; stability of the Company's manufacturing facilities and suppliers, as well as consumer demand for its products, in light of disease epidemics and health-related concerns such as the COVID-19 global pandemic; the impact on our business, operations and financial results from the ongoing conflict in Ukraine; the impact that global climate change trends may have on the Company and its suppliers and customers; the Company's ability to protect patents, trademarks and other intellectual property rights; any breaches of, or interruptions in, its information systems; the ability of its information technology systems or information security systems to operate effectively, including as a result of security breaches, viruses, hackers, malware, natural disasters, vendor business interruptions or other causes; its ability to properly maintain, protect, repair or upgrade its information technology systems or information security systems, or problems with its transitioning to upgraded or replacement systems; the impact of adverse publicity about the Company and/or its brands, including without limitation, through social media or in connection with brand damaging events and/or public perception; fluctuations in the price, availability and quality of raw materials and contracted products as well as foreign currency fluctuations; its ability to utilize potential net operating loss carryforwards; and changes in tax laws and liabilities, tariffs, legal, regulatory, political and economic risks. More information on potential factors that could affect the Company's financial results is included from time to time in the Company's public reports filed with the Securities and Exchange Commission, including the Company's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. All forward-looking statements included in this Presentation are based upon information available to the Company as of the date of this Presentation and speak only as of the date hereof. The Company assumes no obligation to update any forward-looking statements to reflect events or circumstances after the date of this presentation.

USE OF PROJECTIONS

This Presentation contains projected financial information with respect to the Company. Such projected financial information constitutes forward-looking information and is for illustrative purposes only and should not be relied upon as necessarily being indicative of future results. The assumptions and estimates underlying such financial information are inherently uncertain and are subject to a wide variety of significant business, economic, competitive, and other risks and uncertainties. See "Forward-Looking Statements" above. Actual results may differ materially from the results contemplated by the financial forecast information contained in this Presentation, and the inclusion of such information in this Presentation should not be regarded as a representation by any person that the results reflected in such forecasts will be

achieved.

FINANCIAL INFORMATION; NON-GAAP FINANCIAL MEASURES

Some of the financial information and data contained in this Presentation, such as Adjusted EBITDA, and Adjusted Gross Profit has not been prepared in accordance with United States generally accepted accounting principles ("GAAP"). The Company believes these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to the Company's financial condition and results of operations. The Company's management uses these non-GAAP measures for trend analyses and for budgeting and planning purposes. A reconciliation of these non-GAAP financial measures to the closest GAAP measure is included in the Appendix to the Presentation. You should review the Company's audited financial statements prepared in accordance with

GAAP, which are included in its Annual Report on Form 10-K filed with the SEC. Forward-lookingnon-GAAP financial measures are presented without reconciliations to GAAP measures because the GAAP financial measures are not accessible on a forward-looking basis, and reconciling information is not available without unreasonable effort due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliations. For the same reasons, the Company is unable to address the probable significance of the unavailable information, which could be material to future results.

TRADEMARKS

This Presentation contained trademarks, service marks, trade names, and copyrights of, the Company, and other companies, which are the property of their respective owners.

The information contained herein is as of August 8, 2023, and does not reflect any subsequent events.

2

Manufacturer

of PHA

Biopolymers

used in the

development

and sale of

PHA-based and

PLA-based

biodegradable resins that are responsible and sustainable alternatives to petroleum- based plastics

FAST FACTS

Founded in 2004

480 patents &

15 partnerships with major

(went public in 2020)

pending patent applications

brands and distributors

255

2018 and 2020 recipient

Locations in Georgia,

Teammates

of PLASTICS Innovation

Kentucky and New York

in Bioplastics Award

3

Key Investment Highlights

1

Proprietary PHA-Based Resins

2

Adoption of Sustainable Materials

3

Kentucky Plant Capacity

with Disruptive Performance

is Strategic and Persistent

Serves Near-Term Demand

Certified biodegradable for home compost, natural soil and marine environments

Highly-engineered to run on standard manufacturing equipment

Indistinguishable from petroleum-based plastic to consumers at end-use

Switch to PHA-based resin requires significant customer commitment

Creates brand benefits and mitigates risk from future regulatory mandates and/or consumer focus on environment

Funded joint development partnerships lead to commercial launches

Production rate at or above current target

Nameplate capacity of ~32.5 M LBs of neat PHA, ~65 M LBs of finished resin

At full capacity utilization and current market pricing and mix, expect ~$190 M revenue and very strong contribution margin

4

Ongoing Opportunity for

5

Short, Medium & Long-Term

6

World-Class Teams and a

Margin Expansion

Strategic Finance Initiatives

Powerful Culture

Kentucky utilization increase to drive near-term margin improvement

Bainbridge greenfield plant to be more efficient; drives scale benefits with ~$400 M of new annual capacity

Expect catalytic technology (DCT) to be a high- margin path to new markets, scale benefits and licensing opportunities

Solid liquidity position provides runway to positive EBITDA

Part 2 application for DoE Loan Guarantee to fund greenfield facility accepted; due diligence and term sheet negotiation next

Intellectual property contribution drives favorable partnership economics for stand-up of catalytic PHA production

Deeply capable executive team with cadre of veterans and strong new leaders

Talented engineering, research & development, and technical sales teams

Driven culture with deep commitment to

helping solve global environmental and pollution issues

4

Recent Customer & Business Development Highlights

  • Received acceptance of Part 2 application to Department of Energy Loan Guarantee Program; Invited to now take part in due diligence and term sheet negotiation for potential Department of Treasury Federal Financing for construction of Bainbridge, GA greenfield facility
  • Customer launch of Nodax®-based protective films, shrink wrap and produce bags, all new end-use categories with large market opportunities
  • Columbia Packaging Group secures Nodax®-based straw programs with Checkers and Rally's restaurants and AMC Theatres
  • First of several customers for coffee pods now moving to industrial trials, final validation step to ahead of full rate production
  • Awaiting imminent selection for new customer requiring significant annual volumes of biodegradable straw resin
  • Confident in competitive position for new customer requiring ~15 million pounds of annual volume of Nodax®-based cutlery resin; selection expected in Q3, first shipments expected in late 4Q23 or early 1Q24
  • Continuous innovation effort reveals, pending validation, possible process engineering pathway to improved quality, throughput, and efficiency as well as lower input costs for neat-PHA production

5

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Danimer Scientific Inc. published this content on 08 August 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 August 2023 22:25:05 UTC.